BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6231141)

  • 1. In vitro reversal of fragile-X expression by exogenous thymidine.
    Gardiner GB; Wenger SL; Steele MW
    Clin Genet; 1984 Feb; 25(2):135-9. PubMed ID: 6231141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced sensitivity of lymphoblastoid cells from individuals carrying the mutation for the fragile X syndrome to the clastogenic effects of FUdR.
    Duncan AM
    Mutat Res; 1986 Mar; 173(3):201-5. PubMed ID: 2936953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.
    Glover TW
    Am J Hum Genet; 1981 Mar; 33(2):234-42. PubMed ID: 6452060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fragile X(q27) form of X-linked mental retardation: FUdR as an inducing agent for fra(X)(q27) expression in lymphocytes, fibroblasts, and amniocytes.
    Brookwell R; Daniel A; Turner G; Fishburn J
    Am J Med Genet; 1982 Oct; 13(2):139-48. PubMed ID: 6215863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fluorinated pyrimidine analogues in the induction of the in vitro expression of the fragile X chromosome.
    Vandamme B; Liebaers I; Hens L; Bernheim JL; Roobol C
    Hum Genet; 1988 Aug; 79(4):341-6. PubMed ID: 2970425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular folate distribution in cultured fibroblasts from patients with the fragile X syndrome.
    Popovich BW; Rosenblatt DS; Cooper BA; Vekemans M
    Am J Hum Genet; 1983 Sep; 35(5):869-78. PubMed ID: 6614003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of thymidylate synthase activity in whole blood cultures treated with FUdR.
    Sklower SL; Jenkins EC; Anderson ML; Chan CB; Brown WT
    Am J Med Genet; 1986; 23(1-2):483-90. PubMed ID: 2937302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined effects of FUdR addition and methionine depletion on the X-chromosome fragile site.
    Glover TW; Howard-Peebles PN
    Am J Hum Genet; 1983 Jan; 35(1):117-22. PubMed ID: 6218753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate metabolism in fragile X syndrome cells.
    Wang JC; Erbe RW
    Somat Cell Mol Genet; 1985 Jul; 11(4):353-7. PubMed ID: 3895463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA by cells from patients with the fragile X syndrome.
    Wang JC; Beardsley GP; Erbe RW
    Am J Med Genet; 1985 Aug; 21(4):691-6. PubMed ID: 2992271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of the fragile X using thymidine induction.
    Sutherland GR; Baker E; Purvis-Smith S; Hockey A; Krumins E; Eichenbaum SZ
    Prenat Diagn; 1987 Mar; 7(3):197-202. PubMed ID: 2954037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X expression is decreased by 5-azacytidine and S-adenosylhomocysteine.
    Mixon JC; Dev VG
    Am J Hum Genet; 1983 Nov; 35(6):1270-5. PubMed ID: 6196967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate metabolism in cells from fragile X syndrome patients and carriers.
    Wang JC; Erbe RW
    Am J Med Genet; 1984 Jan; 17(1):303-10. PubMed ID: 6585141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile (X) expression: relationship to the cell cycle.
    CantĂș ES; Jacobs PA
    Hum Genet; 1984; 67(1):99-102. PubMed ID: 6235168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X expression in thymidine-prototrophic and auxotrophic human-mouse somatic cell hybrids under low and high thymidylate stress conditions.
    Hori T; Takahashi E; Tsuji H; Tsuji S; Murata M
    Cytogenet Cell Genet; 1988; 47(4):177-80. PubMed ID: 3416651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile X induction systems in CVS cultures: effect on cytogenetic, PCR, and genomic Southern Blot DNA analyses of the FMR-1 gene.
    Jenkins EC; Morys I; Henderson J; Genovese M; Carter M; Li SY; Houck GE; Ding X; Stark-Houck SL; Dobkin CS
    Am J Med Genet; 1994 Jul; 51(4):436-42. PubMed ID: 7943013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic guidelines for fragile X studies tested in routine practice.
    Dewald GW; Buckley DD; Spurbeck JL; Jalal SM
    Am J Med Genet; 1992 Dec; 44(6):816-21. PubMed ID: 1481854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate metabolism in humans.
    Erbe RW; Wang JC
    Am J Med Genet; 1984 Jan; 17(1):277-87. PubMed ID: 6711600
    [No Abstract]   [Full Text] [Related]  

  • 19. Caffeine enhances fragile (X) expression in somatic cell hybrids.
    Ledbetter DH; Airhart SD; Nussbaum RL
    Am J Med Genet; 1986; 23(1-2):445-55. PubMed ID: 2937299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell type-dependent difference in the distribution and frequency of excess thymidine-induced common fragile sites: T lymphocytes and skin fibroblasts.
    Kuwano A; Murano I; Kajii T
    Hum Genet; 1990 May; 84(6):527-31. PubMed ID: 2338337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.